Pharmafile Logo
Pharmafocus logo
Advanced Search
joachim_hasenmaier

Boehringer Ingelheim makes changes to board

July 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has appointed Dr Joachim Hasenmaier to its board of managing directors. The 52-year-old will take over responsibility for …

Appointment
screen_shot_2012-07-05_at_11

New chairman of the board for Dendreon

July 5, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dendreon, Provenge, johnson, prostate cancer

Dendreon has announced that its president and chief executive John Johnson has assumed the additional title of chairman of the …

Appointment
NHS

NHS Board’s draft ‘mandate’ unveiled

July 5, 2012
Sales and Marketing CCGs, NHS, NHS Commissioning Board

 Health Secretary Andrew Lansley has unveiled the proposed ‘mandate’ for the NHS Commissioning Board, the set of strategic goals the …

News
fraser_black

BioCity Scotland appoints new managing director

July 5, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Scotland, Fraser Black, GE Life Sciences

Former Global Services Solutions director with GE Life Sciences, Fraser Black, has been appointed as managing director of BioCity Scotland, …

Appointment
Advair image

GSK ruling: Another failing, but will the industry learn?

July 4, 2012
Medical Communications, Sales and Marketing GSK, fraud, legal, marketing fine

Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …

News
screen_shot_2012-07-04_at_10

New head at the European Medicines Agency

July 4, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Merck Serono, Stallergenes

Merck Serono’s Enrica Alteri has been appointed by The European Medicines Agency as its new head of Safety and Efficacy …

Appointment
FDA image

Janssen submits tuberculosis pill to FDA

July 4, 2012
Research and Development, Sales and Marketing Bedaquiline, FDA, J&J, JJ, Janssen, tuberculosis

Janssen has submitted its investigational tuberculosis pill bedaquiline for review by the FDA. The firm is seeking a licence for …

News

New chair of the English Pharmacy Board

July 4, 2012
Business Services, Research and Development, Sales and Marketing English Pharmacy Board, Shilpa Gohil

Shilpa Gohil has been elected chair of the English Pharmacy Board at the first meeting of the newly elected board, …

Appointment

Nova Laboratories to supply leukaemia drug across Europe

July 4, 2012
Manufacturing and Production

‘Xaluprine’, a liquid form of childhood leukaemia drug Mercaptopurine, will be distributed to hospital pharmacies across Europe after being granted …

News
Press release
abpi image

Sluggish growth forecast concerns ABPI

July 3, 2012
Sales and Marketing ABPI, NHS, OHE, VBP, government

New forecasts suggest that spending on branded drugs may fall in real terms by 2015, leading the ABPI to call …

News
mark_walport_wellcome_trust

Wellcome Trust appoints UK chief scientific adviser

July 3, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UK government, Wellcome Trust

The director of the Wellcome Trust since 2003 Sir Mark Walport has been appointed to succeed Sir John Beddington as …

Appointment
Alzheimer's brain

MPs warn of dementia delays

July 3, 2012
Research and Development, Sales and Marketing APPG, Alzheimer's, dementia, government

Patients with dementia are facing huge delays in their diagnosis and treatment according to a group of MPs and peers. …

News

Scinopharm Taiwan to build injectable drug facility

July 3, 2012
Manufacturing and Production CMO, HPAPI, R&D, Scinopharm Taiwan

Contract manufacturing organisation Scinopharm Taiwan has said it plans to invest around $37.6 million in a new high-potency active pharmaceutical …

News
screen_shot_2012-07-03_at_10

ICON announces senior clinical and laboratory appointments

July 3, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ICON

ICON, provider of outsourced development services to the pharma, biotech and medical device industries has announced appointments to the senior …

Appointment
rsa

RSA appoints new managing director for RSA Germany

July 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kristian Juergensen, appointment, recruitment firm, rsa

RSA, the life sciences recruitment specialist, has appointed Kristian Juergensen as its new managing director of RSA in Germany. Juergensen …

Appointment

China sets out quality rules for pharma excipients

July 3, 2012
Manufacturing and Production China, GMP, IPEC, manufacturing

China’s State Food & Drug Administration has published a draft regulation laying out a number of new measures for boosting …

News
Merck image

Merck closes Cherokee Pharma plant

July 3, 2012
Manufacturing and Production API, Cherokee Pharmaceuticals, Merck, manufacturing

Merck & Co has decided to close down part of a US plant operated by subsidiary Cherokee Pharmaceuticals after failing …

News

GSK to pay ‘unprecedented’ $3 billion fraud charge

July 3, 2012
Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty

GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …

News
screen_shot_2012-07-03_at_14

Strategic North makes two appointments

July 3, 2012
Business Services, Medical Communications, Sales and Marketing Strategic North

Healthcare strategic marketing agency Strategic North has expanded its team with the appointments of Sandra Du Cross in the role …

Appointment

FDA approves Astellas’ leaky bladder drug

July 3, 2012
Sales and Marketing Astellas, FDA, Myrbetriq, bladder, urology

The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq.   Myrbetriq (mirabegron), the first drug in its class, works …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026